Stock 002399 SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Equities

002399

CNE100000P02

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
10.36 CNY +9.98% Intraday chart for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. +12.73% -11.68%
29/04 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02/04 Shenzhen Hepalink Receives Thai Approval for Blood Clot Drug Exarane MT

Evolution of the average Target Price on Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

c7d991f18933bdc42e.Ue6_BCNTsQbfDC75smupekr-ejE-WTf4KsYHwqp0Kn4.Dr_FcG4Q6DOFaBvIyB_fLSaNJVdNP3ayQY1q-_gWawZllvxDZz3ZfuZfQQ~928a2b6ba51db29a7ac000298cf725a7

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
10.36 CNY
Average target price
6.4 CNY
Spread / Average Target
-38.22%
High Price Target
6.4 CNY
Spread / Highest target
-38.22%
Low Price Target
6.4 CNY
Spread / Lowest Target
-38.22%

Consensus detail

Consensus revision (last 18 months)

Ratings for Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 002399 Stock
  4. Consensus Shenzhen Hepalink Pharmaceutical Group Co., Ltd.